A comparative performance evaluation of 12 HIV-1 viral load testing asssays: advancing the clinical application of HIV-1 nucleic acid testing in China
ABSTRACT HIV-1 viral load testing serves as a critical tool for monitoring antiretroviral therapy efficacy and detecting acute HIV-1 infections. This study evaluated the precision, linearity, and clinical performance of 12 commonly used HIV-1 viral load testing kits in China (including seven domesti...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Society for Microbiology
2025-07-01
|
| Series: | Microbiology Spectrum |
| Subjects: | |
| Online Access: | https://journals.asm.org/doi/10.1128/spectrum.03218-24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849421734394986496 |
|---|---|
| author | Yu Wang Pinliang Pan Wenge Xing Xin Zhang Boxue Han Cong Jin |
| author_facet | Yu Wang Pinliang Pan Wenge Xing Xin Zhang Boxue Han Cong Jin |
| author_sort | Yu Wang |
| collection | DOAJ |
| description | ABSTRACT HIV-1 viral load testing serves as a critical tool for monitoring antiretroviral therapy efficacy and detecting acute HIV-1 infections. This study evaluated the precision, linearity, and clinical performance of 12 commonly used HIV-1 viral load testing kits in China (including seven domestic and five imported kits). Precision analysis revealed that 11 kits achieved intra-assay coefficients of variation (CV%) below 5% for high and medium concentration standards at 10,000 and 1,000 IU/mL, respectively, while only 4 kits maintained comparable precision at low concentration standards (100 IU/mL). All kits showed excellent linear performance across their dynamic ranges (R² = 0.9924–0.9999) and effectively covered the major HIV-1 subtypes circulating in China. Correlation analysis of clinical samples showed strong associations (R² >0.70) in 49 out of 66 kit-pair comparisons, with Bland-Altman agreement analysis confirming good consistency between different kits. Notably, domestic Kit B exhibited minimal deviation (0.004 log10 IU/mL) compared to leading imported assays. Point-of-care testing kits demonstrated performance comparable to laboratory-based systems. However, observed variability in low viral load quantification highlights the need for improved precision to meet stringent clinical requirements for viral suppression monitoring at 50 copies/mL. These findings validate the reliability of domestic kits for clinical application while suggesting further enhancement in low-level viremia detection capabilities.IMPORTANCEHIV-1 viral load (VL) testing is extremely important in monitoring the efficacy of antiretroviral therapy and diagnosing acute HIV-1 infections. In China, the growing demand for nucleic acid testing (NAT) and rapid development of HIV-1 NAT technology have led to the approval of 15 HIV-1 VL kits by 2024, but their performance remains understudied. This study comprehensively evaluates 12 widely used HIV-1 VL kits (seven domestic and five imported) in China, demonstrating high precision, linearity, and clinical accuracy across prevalent HIV-1 subtypes in China. Notably, domestic kits exhibited a strong correlation with imported kits, validating their reliability for clinical use. However, variability in low VL quantification highlights challenges in meeting the stringent suppression threshold of 50 copies/mL. These findings provide evidence for optimizing HIV-1 NAT strategies, supporting the adoption of cost-effective domestic kits, and guiding future improvements for low-level viremia monitoring. |
| format | Article |
| id | doaj-art-3ddc7628238a45dcab70744e5ed6324d |
| institution | Kabale University |
| issn | 2165-0497 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | American Society for Microbiology |
| record_format | Article |
| series | Microbiology Spectrum |
| spelling | doaj-art-3ddc7628238a45dcab70744e5ed6324d2025-08-20T03:31:23ZengAmerican Society for MicrobiologyMicrobiology Spectrum2165-04972025-07-0113710.1128/spectrum.03218-24A comparative performance evaluation of 12 HIV-1 viral load testing asssays: advancing the clinical application of HIV-1 nucleic acid testing in ChinaYu Wang0Pinliang Pan1Wenge Xing2Xin Zhang3Boxue Han4Cong Jin5National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, ChinaNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, ChinaNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, ChinaNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, ChinaNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, ChinaNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, ChinaABSTRACT HIV-1 viral load testing serves as a critical tool for monitoring antiretroviral therapy efficacy and detecting acute HIV-1 infections. This study evaluated the precision, linearity, and clinical performance of 12 commonly used HIV-1 viral load testing kits in China (including seven domestic and five imported kits). Precision analysis revealed that 11 kits achieved intra-assay coefficients of variation (CV%) below 5% for high and medium concentration standards at 10,000 and 1,000 IU/mL, respectively, while only 4 kits maintained comparable precision at low concentration standards (100 IU/mL). All kits showed excellent linear performance across their dynamic ranges (R² = 0.9924–0.9999) and effectively covered the major HIV-1 subtypes circulating in China. Correlation analysis of clinical samples showed strong associations (R² >0.70) in 49 out of 66 kit-pair comparisons, with Bland-Altman agreement analysis confirming good consistency between different kits. Notably, domestic Kit B exhibited minimal deviation (0.004 log10 IU/mL) compared to leading imported assays. Point-of-care testing kits demonstrated performance comparable to laboratory-based systems. However, observed variability in low viral load quantification highlights the need for improved precision to meet stringent clinical requirements for viral suppression monitoring at 50 copies/mL. These findings validate the reliability of domestic kits for clinical application while suggesting further enhancement in low-level viremia detection capabilities.IMPORTANCEHIV-1 viral load (VL) testing is extremely important in monitoring the efficacy of antiretroviral therapy and diagnosing acute HIV-1 infections. In China, the growing demand for nucleic acid testing (NAT) and rapid development of HIV-1 NAT technology have led to the approval of 15 HIV-1 VL kits by 2024, but their performance remains understudied. This study comprehensively evaluates 12 widely used HIV-1 VL kits (seven domestic and five imported) in China, demonstrating high precision, linearity, and clinical accuracy across prevalent HIV-1 subtypes in China. Notably, domestic kits exhibited a strong correlation with imported kits, validating their reliability for clinical use. However, variability in low VL quantification highlights challenges in meeting the stringent suppression threshold of 50 copies/mL. These findings provide evidence for optimizing HIV-1 NAT strategies, supporting the adoption of cost-effective domestic kits, and guiding future improvements for low-level viremia monitoring.https://journals.asm.org/doi/10.1128/spectrum.03218-24HIV-1 viral load testingperformance evaluationnucleic acid testinglow-level viremiapoint-of-care testing |
| spellingShingle | Yu Wang Pinliang Pan Wenge Xing Xin Zhang Boxue Han Cong Jin A comparative performance evaluation of 12 HIV-1 viral load testing asssays: advancing the clinical application of HIV-1 nucleic acid testing in China Microbiology Spectrum HIV-1 viral load testing performance evaluation nucleic acid testing low-level viremia point-of-care testing |
| title | A comparative performance evaluation of 12 HIV-1 viral load testing asssays: advancing the clinical application of HIV-1 nucleic acid testing in China |
| title_full | A comparative performance evaluation of 12 HIV-1 viral load testing asssays: advancing the clinical application of HIV-1 nucleic acid testing in China |
| title_fullStr | A comparative performance evaluation of 12 HIV-1 viral load testing asssays: advancing the clinical application of HIV-1 nucleic acid testing in China |
| title_full_unstemmed | A comparative performance evaluation of 12 HIV-1 viral load testing asssays: advancing the clinical application of HIV-1 nucleic acid testing in China |
| title_short | A comparative performance evaluation of 12 HIV-1 viral load testing asssays: advancing the clinical application of HIV-1 nucleic acid testing in China |
| title_sort | comparative performance evaluation of 12 hiv 1 viral load testing asssays advancing the clinical application of hiv 1 nucleic acid testing in china |
| topic | HIV-1 viral load testing performance evaluation nucleic acid testing low-level viremia point-of-care testing |
| url | https://journals.asm.org/doi/10.1128/spectrum.03218-24 |
| work_keys_str_mv | AT yuwang acomparativeperformanceevaluationof12hiv1viralloadtestingasssaysadvancingtheclinicalapplicationofhiv1nucleicacidtestinginchina AT pinliangpan acomparativeperformanceevaluationof12hiv1viralloadtestingasssaysadvancingtheclinicalapplicationofhiv1nucleicacidtestinginchina AT wengexing acomparativeperformanceevaluationof12hiv1viralloadtestingasssaysadvancingtheclinicalapplicationofhiv1nucleicacidtestinginchina AT xinzhang acomparativeperformanceevaluationof12hiv1viralloadtestingasssaysadvancingtheclinicalapplicationofhiv1nucleicacidtestinginchina AT boxuehan acomparativeperformanceevaluationof12hiv1viralloadtestingasssaysadvancingtheclinicalapplicationofhiv1nucleicacidtestinginchina AT congjin acomparativeperformanceevaluationof12hiv1viralloadtestingasssaysadvancingtheclinicalapplicationofhiv1nucleicacidtestinginchina AT yuwang comparativeperformanceevaluationof12hiv1viralloadtestingasssaysadvancingtheclinicalapplicationofhiv1nucleicacidtestinginchina AT pinliangpan comparativeperformanceevaluationof12hiv1viralloadtestingasssaysadvancingtheclinicalapplicationofhiv1nucleicacidtestinginchina AT wengexing comparativeperformanceevaluationof12hiv1viralloadtestingasssaysadvancingtheclinicalapplicationofhiv1nucleicacidtestinginchina AT xinzhang comparativeperformanceevaluationof12hiv1viralloadtestingasssaysadvancingtheclinicalapplicationofhiv1nucleicacidtestinginchina AT boxuehan comparativeperformanceevaluationof12hiv1viralloadtestingasssaysadvancingtheclinicalapplicationofhiv1nucleicacidtestinginchina AT congjin comparativeperformanceevaluationof12hiv1viralloadtestingasssaysadvancingtheclinicalapplicationofhiv1nucleicacidtestinginchina |